Knollwood Investment Advisory LLC Sells 1,074 Shares of HCA Healthcare, Inc. $HCA

Knollwood Investment Advisory LLC lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 33.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,100 shares of the company’s stock after selling 1,074 shares during the period. Knollwood Investment Advisory LLC’s holdings in HCA Healthcare were worth $895,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of HCA. Laird Norton Wetherby Wealth Management LLC grew its stake in HCA Healthcare by 1.4% in the 3rd quarter. Laird Norton Wetherby Wealth Management LLC now owns 5,110 shares of the company’s stock valued at $2,178,000 after buying an additional 70 shares during the last quarter. Lido Advisors LLC boosted its holdings in shares of HCA Healthcare by 18.5% during the third quarter. Lido Advisors LLC now owns 7,824 shares of the company’s stock worth $3,335,000 after acquiring an additional 1,221 shares during the period. Integrated Wealth Concepts LLC increased its stake in shares of HCA Healthcare by 13.4% during the third quarter. Integrated Wealth Concepts LLC now owns 2,744 shares of the company’s stock worth $1,170,000 after purchasing an additional 325 shares during the period. JPL Wealth Management LLC bought a new stake in HCA Healthcare in the 3rd quarter valued at $33,000. Finally, Hilltop Holdings Inc. bought a new position in HCA Healthcare during the 3rd quarter worth $255,000. 62.73% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently commented on HCA shares. Sanford C. Bernstein set a $541.00 price target on shares of HCA Healthcare in a research note on Monday, February 9th. Leerink Partners increased their target price on shares of HCA Healthcare from $507.00 to $573.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 28th. Argus lifted their price target on shares of HCA Healthcare from $530.00 to $560.00 and gave the company a “buy” rating in a research report on Friday, February 6th. Royal Bank Of Canada increased their price target on HCA Healthcare from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 28th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a research report on Monday, December 29th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $537.73.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 1,500 shares of the company’s stock in a transaction that occurred on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the transaction, the executive vice president directly owned 30,003 shares in the company, valued at $14,944,194.27. This represents a 4.76% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Jennifer Berres sold 8,020 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the sale, the senior vice president owned 11,993 shares in the company, valued at $6,171,357.94. This represents a 40.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 15,214 shares of company stock valued at $7,797,595. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $525.12 on Tuesday. The company’s 50 day simple moving average is $508.00 and its 200 day simple moving average is $471.31. HCA Healthcare, Inc. has a 1 year low of $314.43 and a 1 year high of $556.52. The stock has a market capitalization of $117.43 billion, a price-to-earnings ratio of 18.50, a price-to-earnings-growth ratio of 1.64 and a beta of 1.34.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. During the same quarter last year, the business posted $6.22 EPS. The company’s revenue was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be issued a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.99%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.